Anmelden

Yuchuan Jiang

Department of Hepatobiliary Surgery,
The First Affiliated Hospital,
Department of Hepatobiliary Surgery, The First Affiliated Hospital

jinan university

BIOGRAPHY

Yuchuan Jiang has not added Biography.

If you are Yuchuan Jiang and would like to personalize this page please email our Author Liaison for assistance.

PUBLICATIONS

CD215+ Myeloid Cells Respond to Interleukin 15 Stimulation and Promote Tumor Progression.

Frontiers in immunology , 2017 | Pubmed ID: 29255466

Dexmedetomidine promotes the progression of hepatocellular carcinoma through hepatic stellate cell activation.

Experimental & molecular medicine Jul, 2020 | Pubmed ID: 32632241

Pyruvate Kinase M2 Tetramerization Protects against Hepatic Stellate Cell Activation and Liver Fibrosis.

The American journal of pathology Nov, 2020 | Pubmed ID: 32805235

Intrahepatic cholangiocarcinoma induced M2-polarized tumor-associated macrophages facilitate tumor growth and invasiveness.

Cancer cell international Dec, 2020 | Pubmed ID: 33372604

Inflammatory microenvironment of fibrotic liver promotes hepatocellular carcinoma growth, metastasis and sorafenib resistance through STAT3 activation.

Journal of cellular and molecular medicine Feb, 2021 | Pubmed ID: 33410581

Myofibroblast-Specific Msi2 Knockout Inhibits HCC Progression in a Mouse Model.

Hepatology (Baltimore, Md.) 07, 2021 | Pubmed ID: 33609283

TANK-Binding Kinase 1 (TBK1) Serves as a Potential Target for Hepatocellular Carcinoma by Enhancing Tumor Immune Infiltration.

Frontiers in immunology , 2021 | Pubmed ID: 33679751

Postoperative Adjuvant Hepatic Arterial Infusion Chemotherapy With FOLFOX in Hepatocellular Carcinoma With Microvascular Invasion: A Multicenter, Phase III, Randomized Study.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology Dec, 2022 | Pubmed ID: 36525610

Serine/threonine kinase TBK1 promotes cholangiocarcinoma progression via direct regulation of β-catenin.

Oncogene May, 2023 | Pubmed ID: 36928362

A novel prognostic biomarker: is correlated with methylation and immune escape in liver hepatocellular carcinoma.

Translational cancer research May, 2023 | Pubmed ID: 37304536

Noncanonical regulation of HOIL-1 on cancer stemness and sorafenib resistance identifies pixantrone as a novel therapeutic agent for hepatocellular carcinoma.

Hepatology (Baltimore, Md.) Oct, 2023 | Pubmed ID: 37820061

GINS1 promotes ZEB1-mediated epithelial-mesenchymal transition and tumor metastasis via β-catenin signaling in hepatocellular carcinoma.

Journal of cellular physiology May, 2024 | Pubmed ID: 38468464

INSTITUTIONS

jinan university

the First Affiliated Hospital, Jinan University

The Second Affiliated Hospital, Nanchang University

the second affiliated hospital of nanchang university

JOVE ARTICLES

Laparoscopic Common Bile Duct Exploration in Patients with a Previous History of Biliary Tract Surgery

Junjie Liang^*,1,

Jiexing Li^*,1,

Yuchuan Jiang¹,

Qiang Li¹,

Zhilong Liu¹,

Leyang Xiang¹,

Youzhu Hu^1,2,

Mingrong Cao¹

¹Department of Hepatobiliary Surgery, The First Affiliated Hospital, Jinan University,

²Department of General Surgery, The Affiliated Shunde Hospital, Jinan University

Medicine

Laparoscopic Posterior Radical Antegrade Modular Pancreatosplenectomy for Distal Pancreatic Carcinoma

Junjie Liang^*,1,

Quan Jiang^*,1,

Leyang Xiang^*,1,

Yuchuan Jiang^1,2,

Jiexing Li¹,

Zhilong Liu¹,

Qiang Li¹,

Mingrong Cao¹,

Youzhu Hu^1,3,

Jian Sun¹

¹Department of Hepatobiliary Surgery, The First Affiliated Hospital, Jinan University,

²Department of Gastroenterology, The Second Affiliated Hospital, Nanchang University,

³Department of General Surgery, The Affiliated Shunde Hospital, Jinan University

Medicine

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Qiang Li^*,1,

Xiaolan Wang^*,1,2,

Deju Li^*,1,

Yulong Liu^*,3,

Kangshou Liu¹,

Junjie Liang¹,

Jian Sun¹,

Quan Jiang¹,

Jiexing Li¹,

Zhilong Liu¹,

Jian Gong⁴,

Leyang Xiang¹,

Zhidong Jia¹,

Zhiwei Chen¹,

Mingrong Cao¹,

Yuchuan Jiang^1,5

¹Department of Hepatobiliary Surgery, The First Affiliated Hospital, Jinan University,

²Dongpu Branch, The First Affiliated Hospital, Jinan University,

³Department of Vascular Intervention, The First Affiliated Hospital, Jinan University,

⁴Department of Nuclear Medicine, The First Affiliated Hospital, Jinan University,

⁵Department of Gastroenterology, The Second Affiliated Hospital of Nanchang University

Medicine

Datenschutz

Nutzungsbedingungen

Richtlinien

Kontakt

BIBLIOTHEKS-EMPFEHLUNG

JoVE-Newsletter

Forschung

JoVE Journal
Methodensammlungen
JoVE Encyclopedia of Experiments
Archiv

Lehre

JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
Ressourcen für Lehrende
Faculty Site

Autoren

Übersicht
Veröffentlichungsprozess
Redaktionsausschuss
Umfang und Richtlinien
Peer Review
Häufig gestellte Fragen
Einreichen

Bibliothekare

Übersicht
Erfahrungsberichte
Lizenzen
Zugang
Ressourcen
Bibliotheksbeirat
Häufig gestellte Fragen

ÜBER JoVE

Übersicht
Geschäftsführung
Blog
JoVE Help Center

Yuchuan Jiang

.css-o250i3{font-size:18px;font-family:Open Sans,sans-serif;line-height:21.6px;}Department of Hepatobiliary Surgery,The First Affiliated Hospital,Department of Hepatobiliary Surgery, The First Affiliated Hospital

jinan university

Laparoscopic Common Bile Duct Exploration in Patients with a Previous History of Biliary Tract Surgery

Laparoscopic Posterior Radical Antegrade Modular Pancreatosplenectomy for Distal Pancreatic Carcinoma

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Department of Hepatobiliary Surgery,
The First Affiliated Hospital,
Department of Hepatobiliary Surgery, The First Affiliated Hospital